Investors of Hims & Hers file lawsuit over suspected securities fraud in second quarter of 2025.

A securities class action lawsuit was recently filed by Wolf Haldenstein Adler Freeman & Herz LLP, representing investors who bought securities of Hims & Hers Health, Inc. between April 29, 2025, and June 23, 2025. The legal complaint suggests that the company issued deceptive and inaccurate statements concerning its telehealth operations, particularly its partnership with Novo Nordisk A/S. Individuals who obtained Hims & Hers securities within this time frame can participate in the lawsuit and provide their details by August 25, 2025.

The securities lawsuit contends that Hims & Hers Health, Inc. neglected to disclose crucial information to its investors. These omissions relate to the company’s telehealth segment, a significant component of its business, and its purported alliance with Novo Nordisk A/S. Investors who relied on the accuracy and completeness of Hims & Hers financial statements and subsequently suffered losses due to this alleged misleading information may be eligible to participate in the legal proceedings.

Investors who bought Hims & Hers Health, Inc. securities during the aforementioned Class Period are urged to take action before August 25, 2025, to ensure their participation in the securities class action lawsuit. By coming forward and providing their contact information, investors may strengthen the case against Hims & Hers and potentially recover losses incurred as a result of the alleged misrepresentations by the company.

The securities class action lawsuit aims to hold Hims & Hers Health, Inc. accountable for its purported misstatements and omissions that have potentially harmed investors. Investors who were negatively impacted by the discrepancies between the company’s actual business operations and the information provided to the public may seek redress through this legal action. By joining the lawsuit, investors can collectively address the alleged wrongdoing and seek remedies for any financial losses sustained during the Class Period.

Wolf Haldenstein Adler Freeman & Herz LLP’s securities class action lawsuit highlights the importance of transparency and accuracy in financial disclosures made by publicly traded companies. Investors rely on the information disclosed by companies to make informed decisions about their investments, and any misleading or false statements can have serious consequences. Through legal action, investors affected by such discrepancies can seek justice and hold companies accountable for their actions, ensuring greater accountability and transparency in the financial markets.